Liquidity Radar · DFW

Up to $288M is coming to 66 DFW insiders.

As of Oct 31, 2026, six DFW companies are being sold. Filings show what insiders get at five of them. The sixth is a $2.6B private sale, not in that total. Five should close by year-end. Range follows in early 2027.

Range Resources $164.6MInteger Holdings $52.5MMapleMark Bank $49.1MDistribution Solutions $12.1MSanara MedTech $9.5MIncludes severance (paid only if let go). Range and MapleMark are paid in stock and include shares owned.
Are filings right?

Arcosa, Dallas: the filing showed $166.7M for 13 insiders, 81 days early. They got $184.0M. See each person

Filing said$166.7M
They got$184.0M

Who's next in DFW

Every number links to its source.

Range Resources

Natural gas producer. Paid in EQT stock, not cash.

Fort Worth, TX · Buyer: EQT · ~$55/share in EQT stock

$164.6Mto 10 insiders. Change-in-control pay plus shares owned.
Close: Q1 2027Signed Oct 25. No merger proxy yet. Both companies' shareholders must vote.

Top payouts

Photo of Dennis L. Degner
Dennis L. Degner (LinkedIn)CEO
Photo of Mark S. Scucchi
Mark S. Scucchi (LinkedIn)CFO
Photo of Erin W. McDowell
Erin W. McDowell (LinkedIn)General Counsel
+7 more
Photo of Greg G. Maxwell
Greg G. Maxwell (LinkedIn)Chairman
Photo of Laith K. Sando
Laith K. SandoSenior Vice President, Corporate Strategy
Photo of Brenda A. Cline
Brenda A. ClineDirector
Photo of Margaret K. Dorman
Margaret K. DormanDirector
Photo of Christian S. Kendall
Christian S. KendallDirector
Photo of Charles G. Griffie
Charles G. Griffie (LinkedIn)Director
Photo of Reginal W. Spiller
Reginal W. SpillerDirector

Deal team

Gibson, Dunn & CrutcherLawyers for Range Resources Photo of Tull FloreyTull Florey source ↗Photo of Jeffrey A. ChapmanJeffrey A. Chapman source ↗
Kirkland & EllisLawyers for the buyer David B. Feirstein source ↗Cyril V. Jones source ↗
EvercoreBankers for Range Resources filing ↗
J.P. Morgan SecuritiesBankers for Range Resources filing ↗
CitiBankers for the buyer filing ↗
RBC Capital MarketsBankers for the buyer filing ↗
Filings
  • No merger proxy yet, so these are not golden parachute figures. They come from Range's 2026 annual proxy and will change when the merger proxy is filed.
  • Change-in-control figures are as of 2025-12-31 at $35.26 a share, well below the deal value. They are paid in full only if the person is let go. CEO Dennis Degner is set to join EQT's board.
  • Shares owned are from the annual proxy (2026-03-16), less open-market sales and plus director grants on later Form 4s. They are valued here at $54.66 (0.987 x EQT's $55.38 close on 2026-10-30). The value moves with EQT stock.
  • Unvested stock and performance units are not in the shares-owned figure. 2026 executive grants are left out, so executive totals are likely low.
  • Alan Farquharson, a named executive in the proxy, is left out. The proxy says he planned to retire in June 2026.

8-K (merger agreement) · Oct 26, 2026 ↗   Press release · Oct 26, 2026 ↗   DEF 14A (change-in-control table, holdings) · Mar 31, 2026 ↗   10-Q (subsequent event) · Oct 27, 2026 ↗

Integer Holdings

Plano, TX · Buyer: KKR · $127/share cash

$52.5Mto 20 insiders
Close: By year-endShareholders approved Oct 21. Awaiting regulators. Lawsuits filed.

Top payouts

Photo of Payman Khales
Payman Khales (LinkedIn)President and CEO
Photo of Diron Smith
Diron Smith (LinkedIn)CFO
Photo of Jim Stephens
Jim Stephens (LinkedIn)President, Cardiac Rhythm Management & Neuromodulation
+17 more
Photo of Andrew Senn
Andrew SennPresident, Cardio & Vascular
Lindsay K. BlackwoodGeneral Counsel
Joseph W. DziedzicFormer CEO
John Harrisexecutive officer
Tony Carrexecutive officer
Kirk Thorexecutive officer
Milo Metcalfexecutive officer
Donald J. Spencenon-employee director
M. Craig Maxwellnon-employee director
Sheila Antrumnon-employee director
Cheryl C. Cappsnon-employee director
Michael J. Coylenon-employee director
James Flanagannon-employee director
James F. Hinrichsnon-employee director
Alvin (Tyrone) Jeffersnon-employee director
Aaron Kapitonon-employee director
Filippo Passerininon-employee director

Deal team

Davis Polk & WardwellLawyers for Integer Holdings Photo of James P. DoughertyJames P. Dougherty source ↗
Kirkland & EllisLawyers for the buyer Jennifer S. Perkins source ↗David M. Klein source ↗
Goldman SachsBankers for Integer Holdings filing ↗
Centerview, Barclays, Citi, Raymond JamesBankers for the buyer filing ↗
Filings
  • Golden parachute figures assume closing on 2026-09-08 and a qualifying termination right after closing; cash severance is double-trigger. 'Other' = executive retention bonuses.
  • If closing slips past 2027-01-15, ITGR may grant up to $23 million of 2027 RSUs that convert to cash, so actual amounts could rise.
  • KKR's advisors per the deal press release: Centerview, Barclays, Citi and Raymond James. Lead arrangers: Citi, KKR Capital Markets, Barclays, UBS and Jefferies.
  • Three shareholder suits seek to block the merger, plus 13 demand letters (8-K, 2026-10-14). KKR filed a Schedule 13D on 2026-10-13 reporting 4,753,677 shares.

8-K (1.01 merger agreement) · Aug 4, 2026 ↗   PREM14A · Sep 3, 2026 ↗   DEFM14A · Sep 14, 2026 ↗   8-K (5.07 vote result) · Oct 21, 2026 ↗   8-K (HSR early termination) · Sep 30, 2026 ↗

MapleMark Bank

Private Dallas bank. Paid in Scotiabank stock, not cash.

Dallas, TX · Buyer: Scotiabank · ~$11/share in Scotiabank stock

$49.1Mto 16 insiders. Shares owned plus change-in-control and retirement pay.
Close: Q4 2026Holders approve by written consent, no meeting. Bank regulators must clear it.

Top payouts

Anthony B. DavisCEO
Eric L. DavisPresident
Justin CoxDirector
+14 more
Robert LangholzDirector
Frank MurphyDirector
Don KivowitzDirector
Jay HelmDirector
William Wolfe (LinkedIn)CFO
Gerald Shaughnessy Sutton (LinkedIn)Chief Lending Officer
Daryl Kirkham (LinkedIn)Director
John McNicholasDirector
William Prieur (LinkedIn)Dallas Market President
Rob Jentz (LinkedIn)COO
Hudson WhiteDirector
Ethan UnderwoodDirector
Charlie Reeves (LinkedIn)Chief Commercial Officer
Five executivesChange-in-control and retirement pay, not split by person

Deal team

Norton Rose Fulbright USLawyers for MapleMark Bank Bryn A. Sappington source ↗Evan Hardee source ↗
Sullivan & CromwellLawyers for the buyer Stephen M. Salley source ↗
StephensBankers for MapleMark Bank James Clingman source ↗Pablo Vazquez source ↗
Filings
  • $11.37 a share is the F-4's estimate, assuming $106.6M of closing equity. The real price is ($25M + closing equity) / all shares, paid in Scotiabank stock.
  • Values are shares from the F-4 ownership table x $11.37, computed here. Options and warrants are left out, so these are slightly low.
  • Change-in-control pay ($7,069,825) assumes a qualifying exit on 2026-12-01, and some of it depends on that. Retirement plan pay (about $5.0M) is the gross figure. The filing gives only totals.
  • Director Boris Gutin (6.77%) is left out. His shares belong to GCP Capital funds.

F-4/A (Scotiabank) · Jul 24, 2026 ↗

Distribution Solutions

Owns Lawson Products, TestEquity, Gexpro Services

Fort Worth, TX · Buyer: LKCM Headwater (going private) · $35/share cash

$12.1Mto 9 insiders
Close: Q4 2026Final proxy filed Oct 28. Shareholders vote Nov 27.

Top payouts

Photo of Cesar A. Lanuza
Cesar A. Lanuza (LinkedIn)CEO, Lawson
Photo of Ronald J. Knutson
Ronald J. Knutson (LinkedIn)CFO
Photo of Barry Litwin
Barry Litwin (LinkedIn)CEO, TestEquity
+6 more
Robert H. ConnorsCEO, Gexpro Services
I. Steven EdelsonDirector
Lee S. HillmanDirector
Mark F. MoonDirector
Bianca A. RhodesDirector
Robert S. ZamarripaDirector

Deal team

McDermott Will & SchulteLawyers for Distribution Solutions Heidi J. Steele source ↗Eric Orsic source ↗
Mayer BrownLawyers for the buyer Andrew Noreuil source ↗Ryan Ferris source ↗
William Blair & CompanyBankers for Distribution Solutions filing ↗
J.P. Morgan SecuritiesBankers for the buyer filing ↗
Filings
  • Insider-led take-private: LKCM (Fort Worth) already owns 78.5% and keeps it. The cash goes to the ~21.5% public float, not mainly to insiders.
  • Golden parachute cash is severance on a qualifying termination (salary continuation), not triggered by the change in control itself.
  • David Lambert (executive officer, options $287,130) and M. Bradley Wallace (director, no awards) omitted from payouts for lack of a golden-parachute or award amount beyond that line.
  • Also filed 2026-09-01: PREM14A and Schedule 13E3 (going-private disclosure).
  • Final proxy (DEFM14A) filed 2026-10-28 sets the special meeting for 2026-11-27. Its payout tables match the figures here.

8-K (1.01 merger agreement) · Jul 16, 2026 ↗   PRER14A (revised preliminary proxy) · Oct 20, 2026 ↗   DEFM14A (final proxy) · Oct 28, 2026 ↗

Sanara MedTech

Fort Worth, TX · Buyer: MiMedx · ~$35/share cash + stock

$9.5Mto 11 insiders
Close: Q4 2026, may slipShareholders approved Sep 30. FTC asked for more info Oct 15.

Top payouts

Photo of Seth D. Yon
Seth D. Yon (LinkedIn)CEO
Photo of Elizabeth B. Taylor
Elizabeth B. Taylor (LinkedIn)CFO
Photo of Jacob A. Waldrop
Jacob A. WaldropCOO
+8 more
Robert A. DeSutterDirector
Roszell Mack IIIDirector
Eric D. TanzbergerDirector
Eric D. MajorDirector
Sara N. OrtweinDirector
Keith G. MyersDirector
Ronald T. NixonFormer CEO
Ann Beal SalamoneDirector

Deal team

Alston & BirdLawyers for Sanara MedTech filing ↗
Greenberg TraurigLawyers for the buyer filing ↗
Truist SecuritiesBankers for Sanara MedTech filing ↗
Centerview PartnersBankers for the buyer filing ↗
Filings
  • Golden parachute figures assume closing 2026-11-01 and $35.00 per share. Cash includes retention bonus, severance and pro rata bonus.
  • Close timing is at risk: the FTC Second Request (2026-10-15) means Q4 2026 may slip. No new date was stated.
  • Muppalla (former Tissue Health Plus CEO) has $0 in the golden parachute table and is omitted.
  • Nixon-affiliated entities hold 39% of shares (3,575,832; he has sole power over 64,042). His personal economic share is not disclosed. Part of the price is MiMedx stock, so it is not all cash.
  • $35.00 is the value at signing ($33.00 cash + 0.4735 MiMedx share). The share ratio is fixed, so the value moves with MiMedx stock.

8-K (1.01 merger agreement) · Jul 29, 2026 ↗   DEFM14A (proxy statement/prospectus) · Sep 4, 2026 ↗   8-K (5.07 vote result, HSR update) · Oct 1, 2026 ↗   8-K (8.01 FTC Second Request) · Oct 16, 2026 ↗   DEF 14A (2026 annual proxy, share ownership) · Apr 17, 2026 ↗   DEF 14A (ownership footnotes) · Apr 17, 2026 ↗

Vaquero Midstream

Private Permian gas pipelines and plants.

Dallas, TX · Buyer: Energy Transfer · $1.95B cash + 33.3M units

$2.6Bsale price. Who gets what is not public.
Close: Q4 2026Announced Oct 6. Needs regulatory approval. No shareholder vote.

Who runs it

Photo of Harrison Holmes
Harrison HolmesChief Executive Officer
Photo of Bryant Patton
Bryant Patton (LinkedIn)Chairman and Chief Financial Officer
Photo of Wayne Wauson
Wayne Wauson (LinkedIn)Chief Operating Officer
Photo of Sandra Fendley
Sandra Fendley (LinkedIn)Executive Vice President, Chief Accounting Officer

Deal team

Willkie Farr & GallagherLawyers for Vaquero Midstream Photo of Jesse BettsJesse Betts source ↗Photo of Jessica HammonsJessica Hammons source ↗
Sidley AustinLawyers for the buyer George Vlahakos source ↗Atman Shukla source ↗
Houlihan LokeyBankers for Vaquero Midstream filing ↗
J.P. Morgan SecuritiesBankers for the buyer filing ↗
Filings
  • Private company, so no SEC filing shows who gets what. The $2.625B is the sale price, not a payout to one person, and it is left out of the headline total.
  • Sources are the advisers' announcements and press coverage, not SEC filings.
  • Vaquero's investors include Yorktown Partners (New York) and Keeneland Capital, so much of the price likely goes to funds. Management's share is not disclosed.

Willkie announcement · Oct 6, 2026 ↗   Sidley announcement · Oct 6, 2026 ↗

Proof: Arcosa

CRH bought Arcosa (Dallas) at $150/share. Filed Aug 3, 2026, closed Oct 23, 2026. Gray: filing. Green: paid. Most of the gap is performance shares paying about 2x target. proxy ↗ closing 8-K ↗

Antonio CarrilloExecutive officer
$91.8M in the filing → $100.8M at close Form 4 ↗
Reid S. EsslExecutive officer
$17.9M in the filing → $19.8M at close Form 4 ↗
Gail M. PeckExecutive officer
$16.2M in the filing → $19.3M at close Form 4 ↗
Bryan P. StevensonExecutive officer
$8.9M in the filing → $10.0M at close Form 4 ↗
Rhys J. BestDirector
$9.1M in the filing → $9.1M at close Form 4 ↗
+8 more
Kerry S. ColeExecutive officer
$6.0M in the filing → $7.8M at close Form 4 ↗
John W. LindsayDirector
$3.0M in the filing → $4.1M at close Form 4 ↗
Joseph AlvaradoDirector
$3.0M in the filing → $3.0M at close Form 4 ↗
Jeffrey A. CraigDirector
$3.0M in the filing → $3.0M at close Form 4 ↗
Melanie M. TrentDirector
$3.0M in the filing → $2.7M at close Form 4 ↗
Steven J. DemetriouDirector
$1.9M in the filing → $1.9M at close Form 4 ↗
Julie A. PiggottDirector
$1.4M in the filing → $1.4M at close Form 4 ↗
Kimberly S. LubelDirector
$1.4M in the filing → $982K at close Form 4 ↗
Method

proxy-table build = (proxy beneficial shares - RSUs already counted in them) x $150 + all RSU award $ from the insider-interests table. actual = Form 4 code D at close (common x $150 + phantom units). Golden parachute shown separately: it only covers change-in-control pay (cash severance needs a later firing, so it never shows on Form 4). Form 4 $ are gross, before tax withholding.

  • Form 4 values are gross at $150. Cash actually received is lower after tax withholding on RSU/PSU payouts.
  • Golden parachute cash severance (e.g. $8.19M for the CEO) is double-trigger: paid only if the person is later let go. It does not appear on Form 4.
  • PSU target vs time-RSU split is implied from Form 4 balances; the proxy reports them combined.
  • Phantom units' Form 4 footnote says price was set as of 2026-09-30, but the price field shows $150; used $150.
  • Hurst is not in the beneficial ownership table, so his forecast misses shares he already owned. Collins filed no Form 4 at close.
  • Trinity deferred RSUs (Carrillo 17,214; Best 69,970) are Trinity Industries shares, not Arcosa, and are excluded.
  • PSU payout rate (~195% of target, cap 200%) is implied from Form 4 share counts; no filing states it.
  • Phantom units: the Form 4 footnote prices them as of 2026-09-30 ($146.15 on that date's Form 4s); valued here at $150. Difference about $47K, unresolved.
  • Trinity Career Share cash bonuses paid at closing (about $861K for Peck, Cole and Essl per the proxy) are left out of both sides.